If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
other |
not provided |
total |
184
|
205
|
1353
|
872
|
138
|
3
|
6
|
5
|
2714
|
Gene and significance breakdown #
Total genes and gene combinations: 35
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
other |
not provided |
total |
GPC3
|
43
|
8
|
428
|
297
|
69
|
0 |
0 |
0 |
837
|
WT1
|
46
|
13
|
393
|
336
|
39
|
0 |
0 |
4
|
803
|
LOC107982234, WT1
|
19
|
4
|
444
|
211
|
12
|
0 |
0 |
0 |
674
|
BRCA2
|
65
|
4
|
70
|
26
|
17
|
0 |
0 |
1
|
183
|
TP53
|
0 |
111
|
0 |
0 |
0 |
0 |
0 |
0 |
111
|
PIK3CA
|
0 |
22
|
0 |
0 |
0 |
0 |
0 |
0 |
22
|
FBXW7
|
0 |
15
|
0 |
0 |
0 |
0 |
0 |
0 |
15
|
REST
|
0 |
0 |
8
|
2
|
0 |
3
|
0 |
0 |
13
|
TRIM28
|
1
|
0 |
6
|
0 |
0 |
0 |
0 |
0 |
7
|
ERBB3
|
0 |
5
|
0 |
0 |
0 |
0 |
0 |
0 |
5
|
PPP2R1A
|
0 |
5
|
0 |
0 |
0 |
0 |
0 |
0 |
5
|
PTEN
|
0 |
5
|
0 |
0 |
0 |
0 |
0 |
0 |
5
|
HRAS, LRRC56
|
0 |
3
|
0 |
0 |
0 |
0 |
0 |
0 |
3
|
POLE
|
0 |
3
|
0 |
0 |
0 |
0 |
0 |
0 |
3
|
CTNNB1, LOC126806658
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
0 |
2
|
H19, H19-ICR, MRPL23
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
LOC106707172, LOC107982234, LOC130005479, WT1
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
LOC130065239, TRIM28
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
MED12
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
0 |
2
|
POU6F2
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
U2AF1
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
BRAF
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
CCDC160, GPC3, HPRT1, MIR106A, MIR19B2, PHF6
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
CHEK2
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
CTNNB1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
0 |
1
|
DCDC1, DNAJC24, ELP4, IMMP1L, PAX6, RCN1, WT1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
DIS3L2
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
ERBB2
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
FGFR2
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
FZD6
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
0 |
1
|
GPC4
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
0 |
1
|
IGF2, INS-IGF2
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
PIK3R1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
SMAD4
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
TET2
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
other |
not provided |
total |
Labcorp Genetics (formerly Invitae), Labcorp
|
99
|
17
|
1146
|
800
|
100
|
0 |
0 |
0 |
2162
|
Fulgent Genetics, Fulgent Genetics
|
71
|
5
|
117
|
56
|
18
|
0 |
0 |
0 |
267
|
All of Us Research Program, National Institutes of Health
|
0 |
2
|
139
|
84
|
4
|
0 |
0 |
0 |
229
|
Database of Curated Mutations (DoCM)
|
0 |
174
|
0 |
0 |
0 |
0 |
0 |
0 |
174
|
Illumina Laboratory Services, Illumina
|
0 |
0 |
72
|
14
|
25
|
0 |
0 |
0 |
111
|
St. Jude Molecular Pathology, St. Jude Children's Research Hospital
|
3
|
0 |
24
|
0 |
0 |
0 |
0 |
0 |
27
|
Genome-Nilou Lab
|
0 |
0 |
0 |
0 |
18
|
0 |
0 |
0 |
18
|
OMIM
|
13
|
0 |
0 |
0 |
0 |
3
|
0 |
0 |
16
|
KCCC/NGS Laboratory, Kuwait Cancer Control Center
|
0 |
0 |
0 |
3
|
10
|
0 |
0 |
0 |
13
|
Mendelics
|
0 |
0 |
11
|
0 |
1
|
0 |
0 |
0 |
12
|
Baylor Genetics
|
4
|
2
|
4
|
0 |
0 |
0 |
0 |
0 |
10
|
Color Diagnostics, LLC DBA Color Health
|
0 |
0 |
0 |
2
|
8
|
0 |
0 |
0 |
10
|
Donald Williams Parsons Laboratory, Baylor College of Medicine
|
2
|
1
|
0 |
0 |
0 |
0 |
6
|
0 |
9
|
Athena Diagnostics
|
0 |
0 |
0 |
0 |
3
|
0 |
0 |
0 |
3
|
GeneReviews
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
3
|
Molecular Genetics and NGS Laboratory, Hospital Fundacion Valle Del Lili
|
2
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
3
|
Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
0 |
2
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
Genetics and Molecular Pathology, SA Pathology
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
Institute of Human Genetics, Clinical Exome/Genome Diagnostics Group, University Hospital Bonn
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Institute of Human Genetics, Cologne University
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Institute for Human Genetics and Genomic Medicine, Uniklinik RWTH Aachen
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
GenomeConnect, ClinGen
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
1
|
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Génétique des Maladies du Développement, Hospices Civils de Lyon
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Johns Hopkins Genomics, Johns Hopkins University
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Pediatric Oncology, Johns Hopkins University
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
NPCF Sunshine Lab, H. Lee Moffitt Cancer Center and Research Institute
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
3billion
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
GenomeConnect - Invitae Patient Insights Network
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
1
|
Laan Lab, Human Genetics Research Group, University of Tartu
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
MVZ Medizinische Genetik Mainz
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.